Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cleanroom Services Partnership Brings Synergy for Customers

Published: Thursday, May 01, 2014
Last Updated: Thursday, May 01, 2014
Bookmark and Share
Two award-winning laboratory service providers have joined forces to create greater synergy for customers.

Two award-winning laboratory service providers have joined forces to create greater synergy for customers. 


Cleanroom manufacturer Connect2Cleanrooms and specialist laboratory relocation provider Andrew Porter Limited have formed a partnership agreement, which is set to complement and enhance each firm’s service provision. 

Connect2Cleanrooms already provides disassembly, relocation and revalidation of its modular cleanrooms, but the new partnership with Andrew Porter Limited will enable it to offer a full relocation service to include all contents of the cleanroom, such as instrumentation and cold chain materials. 

Relocation of other laboratory spaces outside the cleanroom environment can also be provided, offering customers a turnkey solution. 

Andrew Porter Limited will be able to benefit customers through the partnership by providing modular cleanroom facilities, that could be used temporarily or part of a longer term proposition, for phased moves or where a decant into temporary premises is required as part of a larger relocation. 

This service will further enhance the range of additional services already provided by the company, with Connect2Cleanrooms also assisting Andrew Porter Limited in the training of its operatives to ISO14644-1:1999 EU GGMP, and US Federal standards 209E, where appropriate. 

European sales director at Andrew Porter Limited, John Best, commented: “We have a lot in common with Connect2Cleanrooms. We are both experts in our respective fields and are global companies which are headquartered in Lancashire, UK, so I am really pleased that we will be working together moving forward. 

“The technical specialism we are able to offer to each other’s customers makes this a mutually beneficial partnership that enhances both firms’ service offerings.” 

Joe Govier, managing director of Connect2Cleanrooms, said: “We first met with Andrew Porter Limited when we were both winners at this year’s Red Rose Awards. It is fantastic that the winning did not stop there for either of us and that this partnership will benefit both firms and our customer base now and into the future.” 


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!